Cost-effectiveness of biologics in early rheumatoid arthritis
ContributorsFinckh, Axel
Published inAnnals of internal medicine, vol. 152, no. 5, p. 333-334;authorreply334
Publication date2010
Keywords
- Antirheumatic Agents/economics/therapeutic use
- Arthritis, Rheumatoid/drug therapy
- Cost-Benefit Analysis
- Humans
- Immunologic Factors/economics/therapeutic use
Affiliation entities
Research groups
Citation (ISO format)
FINCKH, Axel, BANSBACK, Nick, LIANG, Matthew H. Cost-effectiveness of biologics in early rheumatoid arthritis. In: Annals of internal medicine, 2010, vol. 152, n° 5, p. 333–334;authorreply334. doi: 10.1059/0003-4819-152-5-201003020-00018
Identifiers
- PID : unige:20460
- DOI : 10.1059/0003-4819-152-5-201003020-00018
- PMID : 20194244
Journal ISSN0003-4819
